0001127602-20-027459.txt : 20201023 0001127602-20-027459.hdr.sgml : 20201023 20201023163231 ACCESSION NUMBER: 0001127602-20-027459 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201021 FILED AS OF DATE: 20201023 DATE AS OF CHANGE: 20201023 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HENDERSON LORI M. CENTRAL INDEX KEY: 0001221127 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38753 FILM NUMBER: 201258070 MAIL ADDRESS: STREET 1: MOLDFLOW CORP STREET 2: 430 BOSTON POST ROAD CITY: WAYLAND STATE: MA ZIP: 01778 FORMER NAME: FORMER CONFORMED NAME: HENDERSON LORI M DATE OF NAME CHANGE: 20030228 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Moderna, Inc. CENTRAL INDEX KEY: 0001682852 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 813467528 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 TECHNOLOGY SQUARE CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 6177146500 MAIL ADDRESS: STREET 1: 200 TECHNOLOGY SQUARE CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: Moderna Therapeutics, Inc. DATE OF NAME CHANGE: 20160822 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2020-10-21 0001682852 Moderna, Inc. MRNA 0001221127 HENDERSON LORI M. C/O MODERNA, INC. 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139 1 General Counsel and Secretary Common Stock 2020-10-21 4 M 0 32000 14.85 A 32681 D Common Stock 2020-10-21 4 S 0 1697 68.70 D 30984 D Common Stock 2020-10-21 4 S 0 14148 69.84 D 16836 D Common Stock 2020-10-21 4 S 0 15455 70.56 D 1381 D Common Stock 2020-10-21 4 S 0 700 71.39 D 681 D Stock Option (Right to Buy) 14.85 2020-10-21 4 M 0 32000 0 D 2028-06-26 Common Stock 32000 367522 D The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 6, 2020. Includes 681 shares acquired under the Moderna, Inc. 2018 Employee Stock Purchase Plan on May 29, 2020. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $68.20 to $69.19. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $69.25 to $70.25. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $70.27 to $71.23. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $71.34 to $71.45. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. 25% of this option will vest and become exercisable on April 9, 2019 with the remainder vesting in 12 equal quarterly installments thereafter. /s/ Lori Henderson 2020-10-23